Important mechanistic study on ICAHT from our French colleagues @GustaveRoussy highlighting that lymphodepletion alone is insufficient to explain prolonged cytopenia after CART
…a second inflammation / CAR-mediated hit within the BM is needed 👆
https://t.co/Xtv7rcIUlX
CAR T cells in the bone marrow maintain an activation state that results in inflammation that leads to hypoplasia @ScienceTM@CBigenwald 🇨🇵
https://t.co/un6nejjNpz
Modifying a patient’s gut microbiome may enhance the efficacy of CAR T-cell therapy, according to research from @GustaveRoussy published in the AACR journal @CD_AACR. Learn more on the #AACRBlog: https://t.co/qMQq7lZ5Hf @CBigenwald
Now online in @CD_AACR: Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR-T cell Potency - by Laura Marcos-Kovandzic, @CBigenwald, Laurence Zitvogel, and colleagues https://t.co/YnSGlytP1Y @GustaveRoussy
1/23 We are excited to announce that our most recent study “In vivo dendritic cell reprogramming for cancer immunotherapy” was published in @ScienceMagazine.
https://t.co/yPDqKmpGnn
Here is a summary of what we discovered!
🖼️ Yan Pei-Ming donne un visage à l’Institut avec un portrait monumental du professeur Gustave Roussy.
Exécuté et offert par Yan Pei-Ming, peintre franco-chinois de renommée internationale, le portrait en 2,80 mètres par 2,40 mètres du Pr Gustave Roussy est accroché dans le hall de l’Institut, accueillant les patients, leurs proches, les visiteurs et le personnel.
🎯 Il symbolise la mission et l’héritage du fondateur de l’Institut, père de l’oncologie moderne, dont les travaux continuent d’influencer la recherche contre le #cancer.
Yan Pei-Ming l’a réalisé à l’occasion des 90 ans de la création par le Pr Roussy de l’Institut du Cancer, et des 150 ans de la naissance de ce médecin-chercheur visionnaire.
Lire le communiqué de presse 👉 https://t.co/DtVe8tNBCH
📣 Congratulations to this year's #EHAGrants winners! We look forward to seeing them advance the field of #hematology through new collaborations and resources. Do you have a research idea in need of support? The call for #EHA Grants is now open: https://t.co/usg1y7NBXE
Out in @CellCellPress today! We describe the first humans with inherited, complete FLT3L deficiency. Despite a lack of most dendritic cells, they reached adulthood. See the thread below for the main highlights of our paper. https://t.co/0jPFLfDRQh
Proud to share the results of our study on the effect of prostaglandin E2 on T cells, which was just published in Nature in which we discovered a new role for PGE2 in inhibiting interleukin-2 (IL-2) sensing and signalling in tumor-reactive T cells https://t.co/9Pu6cy0JvA
IMPROVING ADOPTIVE CELL THERAPY
Deadline for abstract submission at : April 2, 2024
Please submit your abstract to the following address:
[email protected]
⏳REGISTER NOW⌛️while there's still ⏲️ for the FREE International ImmunoSchool introducing everyone that's interested to experts from around the 🌍 who will be discussing challenges & opportunities for cancer immunotherapy. Sign up here >>> https://t.co/ZFsmWyMROL
@miriammerad
@FGinhoux Very excited to share SOPA!
This has been a wonderful collaboration with Quentin Blampey, Paul-Henry Cournède and @FGinhoux
We present a technology-invariant pipeline for analyses of image-based spatial-omics. Compatible with the latest technologies!
https://t.co/Y3DWyr3qnE